We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Next Generation Cancer Vaccines—Make It Personal!.
- Authors
Terbuch, Angelika; Lopez, Juanita
- Abstract
Dramatic success in cancer immunotherapy has been achieved over the last decade with the introduction of checkpoint inhibitors, leading to response rates higher than with chemotherapy in certain cancer types. These responses are often restricted to cancers that have a high mutational burden and show pre-existing T-cell infiltrates. Despite extensive efforts, therapeutic vaccines have been mostly unsuccessful in the clinic. With the introduction of next generation sequencing, the identification of individual mutations is possible, enabling the production of personalized cancer vaccines. Combining immune check point inhibitors to overcome the immunosuppressive microenvironment and personalized cancer vaccines for directing the host immune system against the chosen antigens might be a promising treatment strategy.
- Subjects
CANCER vaccines; CANCER immunotherapy; COMBINATION drug therapy; CANCER immunology; INDIVIDUALIZED medicine
- Publication
Vaccines, 2018, Vol 6, Issue 3, p52
- ISSN
2076-393X
- Publication type
Article
- DOI
10.3390/vaccines6030052